論文（邦文）
- AI時代の日本の医療
- 筧善行
香川県医学会誌特別号 香川県医師会 75巻6号 p62-63
- 国民のための名医ランキング
- 杉元幹史
桜の花出版 p358
- 中間リスク前立腺癌に対する監視療法は推奨されるか?
- 杉元幹史, 加藤琢磨, 三塚浩二, 松本隆児, 土肥洋一郎
日本泌尿器科学会編:前立腺癌診療ガイドライン2023年版 メディカルレビュー社 CQ5 p65-71
- 刊行によせて
- 杉元幹史
まるごとわかる尿路カテーテル・ストーマ管理 極 南山堂
- 4.チーマンカテーテル p46-47 8.尿路ストーマ p106-110 9.尿道用ブジー p128-130 10.ウロバッグ p134-135
- 上田修史
まるごとわかる尿路カテーテル・ストーマ管理 極 南山堂
- 1.尿道カテーテル p2-3 2.尿道カテーテル3way p24-25 3.ネラトンカテーテル p34-35
- 松岡祐貴
まるごとわかる尿路カテーテル・ストーマ管理 極 南山堂
- 5.腎瘻 p52-56 6.膀胱瘻 p72-75 7.間欠導尿用カテーテル p86-89
- 宮内康行
まるごとわかる尿路カテーテル・ストーマ管理 極 南山堂
- 泌尿器科的エマージェンシー
- 田岡利宜也
新臨床腫瘍学（改訂第7版） 南江堂
- 抗悪性腫瘍薬（ホルモン療法薬－前立腺癌）
- 田岡利宜也, 筧善行
Pocket Drugs 2023 医学書院 p586-590
- 第4部臨床との連携 1.前立腺癌の標準治療 監視療法
- 土肥洋一郎, 杉元幹史
腫瘍病理鑑別診断アトラス 前立腺癌第2版 p156-162 文光堂 東京 2023
- 泌尿器科領域におけるトラブルシューティング 腹腔鏡下手術時の横隔膜損傷
- 上田修史, 岡添誉, 杉元幹史
泌尿器外科36巻4号 Page343-345
- 腎移植ドナー不足の現状と当院での取り組み
- 上田修史, 田岡利宜也, 杉元幹史
西日本泌尿器科学会雑誌86巻1号 Page1-6
- 筋層浸潤性膀胱癌; Next 10 Years
- 田岡利宜也, 杉元幹史
西日本泌尿器科 85:301-305,2023
- 生体腎移植ドナーにおける腎提供前後の健康関連Quality of lifeの推移
- 田岡利宜也, 上田修史, 杉元幹史
腎移植血管外科研究会 34（2）26-31,2022
- 局所進行性または転移性尿路上皮癌に対する新たな一次治療候補:Enfortumab vedotin+Pembrolizuma併用療法
- 田岡利宜也
URO-ONCOLOGY HUB ( https://urohub.jp/s-papers/uc_027 )
- 高リスク限局性上部尿路上皮癌に対する術前補助化学療法の新規エビデンス：多機関共同第Ⅱ相試験
- 田岡利宜也
URO-ONCOLOGY HUB ( https://urohub.jp/s-papers/uc_028 )
- 筋層浸潤性膀胱癌に対する術前補助化学療法の標準レジメンへ: Dose-dense MVAC療法のQALYs評価
- 田岡利宜也
URO-ONCOLOGY HUB ( https://urohub.jp/s-papers/uc_029/ )
- Active surveillance for early-stage prostate cancer
- 加藤琢磨, 杉元幹史
日本臨床 81巻 臨床前立腺癌-基礎・臨床の最新知見- 5.その他の治療法 （1）監視療法
- 前立腺がん画像診断の進歩と将来展望 AIの基礎と画像診断へのその応用
- 加藤琢磨
西日本泌尿器科 第85巻 4号
- 研究資金獲得のためのクラウドファンディング活用
- 土肥洋一郎, 筧善行, 杉元幹史
日本排尿機能学会誌 第32巻第2号
- 診断に難渋した原発性精嚢癌の一例
- 小橋口佳な, 杉野善雄, 高橋大介, 藤本健尊, 中村友哉, 安松良子, 岩村博史
姫路医療センター紀要 第18巻 P5～9 2023
論文（英文）
- Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer
- Noel W. Clarke, M.B.B.S., Ch.M., F.R.C.S.,1 Andrew J. Armstrong, Sc.M., M.D.,2 Antoine Thiery-Vuillemin, M.D., Ph.D.,3Mototsugu Oya, M.D.,4 Neal Shore, M.D.,5 Eugenia Loredo, M.D.,6 Giuseppe Procopio, M.D.,7 Juliana de Menezes, M.D.,8Gustavo Girotto, M.D.,9 Cagatay Arslan, M.D.,10 Niven Mehra, M.D., Ph.D.,11 Francis Parnis, F.R.A.C.P.,12Emma Brown, M.D.,13 Friederike Schl€urmann, M.D.,14 Jae Y. Joung, M.D., Ph.D.,15 Mikio Sugimoto, M.D., Ph.D.,16Juan A. Virizuela, M.D., Ph.D.,17 Urban Emmenegger, M.D.,18 Jiri Navratil, M.D.,19 Gary L. Buchschacher, Jr., M.D., Ph.D.,20Christian Poehlein, M.D.,21 Elizabeth A. Harrington, Ph.D.,22 Chintu Desai, Ph.D.,23 Jinyu Kang, M.D.,24Fred Saad, M.D., F.R.C.S.,25 for the PROpel Investigators*
NEJM Evidence Published June 3, 2022NEJM Evid 2022;1(9)DOI: 10.1056/EVIDoa2200043VOL.1 NO.9
- Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
- Saad F, Clarke NW, Oya M, Shore N, Procopio G, Guedes JD, Arslan C, Mehra N, Parnis F, Brown E, Schlürmann F, Joung JY, Sugimoto M, Sartor O, Liu YZ, Poehlein C, Barker L, Del Rosario PM, Armstrong AJ.
Lancet Oncol. 2023 Oct;24(10):1094-1108. doi: 10.1016/S1470-2045(23)00382-0. Epub 2023 Sep 12.
PMID: 37714168
- Risk of progression following a negative biopsy in prostate cancer active surveillance
- Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A, Bjartell A, Morgan T, Dasgupta P, Van Hemelrijck M, Elhage O; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium.
Photodiagnosis Photodyn Prostate Cancer Prostatic Dis. 2023
Jun;26(2):403-409. doi: 10.1038/s41391-022-00582-x. Epub 2022 Aug25.PMID: 36008540FreePMC article.
- Detection of intraductal carcinoma in prostate cancer patients with small tumor volume
- Takeshita N, Sakamoto S, Yamada Y, Sazuka T, Imamura Y, Komiya A, Akakura K, Sato N, Nakatsu H, Kato T, Sugimoto M, Tsuzuki T, Ichikawa T.
Prostate. 2023 May;83(6):580-589. doi: 10.1002/pros.24492. Epub 2023 Feb 10.PMID: 36762419
- Patient and Carer Experiences with Bladder Cancer: Results from a Global Survey in 45 Countries
- Makaroff LE, Filicevas A, Boldon S, Hensley P, Black PC, Chisolm S, Demkiw S, Fernández MI, Sugimoto M, Jensen BT, Witjes WPJ, Bagshaw K, Cirefice-Funk L, Knight A, Kamat AM.
Eur Urol. 2023 Aug;84(2):248-251. doi: 10.1016/j.eururo.2023.04.034. Epub 2023 May 24.
PMID: 37236857 No abstract available.
- The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration-resistant prostate cancer in real-world clinical practice: The multi-institutional observational ZENSHIN study
- Uemura H, Oya M, Kamoto T, Sugimoto M, Shinozaki K, Morita K, Koto R, Takahashi M, Nii M, Shin E, Nonomura N.
Cancer Med. 2023 Mar;12(5):5265-5274. doi: 10.1002/cam4.5333. Epub 2022 Nov 10.
PMID: 36358026 Free PMC article.
- Oral 5-aminolevulinic acid administration before transurethral resection of bladder tumor induces perioperative nausea and vomiting
- Taoka R, Yamada K, Sawanobori Y, Honda T, Osaki Y, Abe Y, Naito H, Tohi Y, Matsuoka Y, Kato T, Okazoe H, Ueda N, Sugimoto M
Photodiagnosis Photodyn Ther. 2023 Jul 12;103707. doi: 10.1016/j.pdpdt.
- The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy
- Hiroshi Kikuchi, Takashige Abe, Makito Miyake, Haruka Miyata, Ryuji Matsumoto, Takahiro Osawa, Nobutaka Nishimura, Kiyohide Fujimoto, Junichi Inokuchi, Takahiro Yoneyama, Ryotaro Tomida, Kazuyuki Numakura, Yuto Matsushita, Kazumasa Matsumoto, Takuma Sato, Rikiya Taoka, Takashi Kobayashi, Takahiro Kojima, Yoshiyuki Matsui, Naotaka Nishiyama, Hiroshi Kitamura, Hiroyuki Nishiyama, Nobuo Shinohara
Jpn J Clin Oncol doi: 10.1093/jjco/hyad155
- Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site
- Naotaka Nishiyama, Yuki Kita, Katsuhiro Ito, Minoru Kato, Shingo Hatakeyama, Yuto Matsushita, Sei Naito, Makito Miyake, Shotaro Nakanishi, Yoichiro Kato, Tadamasa Shibuya, Tetsutaro Hayashi, Hiroaki Yasumoto, Takashi Yoshida, Motohide Uemura, Rikiya Taoka, Hiroyuki Nishiyama, Takashi Kobayashi, Hiroshi Kitamura; Japan Urological Oncology Group
Anticancer Res 43(11):5041-5050.
- Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-institutional study in Japan
- Shuichi Morizane, Keita Nakane, Toshiaki Tanaka, Kenji Zennami, Kentaro Muraoka, Shin Ebara, Noriyoshi Miura, Koichi Uemura, Ryuta Sobu, Akio Hoshi, Rikiya Taoka, Mikio Sugimoto, Hisashi Noma, Hiroshi Sunada, Hiroyuki Nishiyama, Tomonori Habuchi, Ichiro Ikeda, Takashi Saika, Kazuhide Makiyama, Ryoichi Shiroki, Naoya Masumori, Takuya Koie, Atsushi Takenaka
Int J Clin Oncol doi: 10.1007/s10147-023-02425-8.
- C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis
- Ryoma Nishikawa, Makito Miyake, Shuichi Morizane, Ryutaro Shimizu, Shogo Teraoka, Masashi Honda, Kota Iida, Nobutaka Nishimura, Tomokazu Sazuka, Takahiro Kimura, Akihiro Ito, Kenichiro Shiga, Rikiya Taoka, Takahiro Kojima, Takashi Kobayashi, Naotaka Nishiyama, Hiroshi Kitamura, Hiroyuki Nishiyama, Kiyohide Fujimoto, Atsushi Takenaka
Int J Urol 30(3):299-307.
- A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer
- Takuma Kato, Yoichiro Tohi, Tomoko Honda, Iori Matsuda, Yu Osaki, Hirohito Naito, Yuki Matsuoka, Homare Okazoe, Rikiya Taoka, Hiroyuki Tsunemori, Nobufumi Ueda, Mikio Sugimoto
Int J Urol. 2023 Mar;30(3):289-297
- A national questionnaire survey of Japanese urologists on treatment perspectives for elderly prostate cancer patients
- Takuma Kato, Yoichiro Tohi, Tomoko Honda, Iori Matsuda, Yu Osaki, Hirohito Naito, Yuki Matsuoka, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto
Int J Urol. 2023 Aug;30(8):672-680
- Detection of intraductal carcinoma in prostate cancer patients with small tumor volume
- Takeshita Nobushige, Sakamoto Shinichi, Yamada Yasutaka, Sazuka Tomokazu, Imamura Yusuke, Komiya Akira, Akakura Koichiro, Sato Nobuo, Nakatsu Hiroomi, Kato Takuma, Sugimoto Mikio, Tsuzuki Toyonori, Ichikawa Tomohiko
Prostate 2023 May;83(6):580-589 doi: 10.1002/pros.24492. Epub 2023 Feb 10.
- Effectiveness and Safety of a Mixture of Nobiletin and Tangeretin in Nocturia Patients: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study
- Haruki Ito, Hiromitsu Negoro, Jin Kono, Naoki Hayata, Takayoshi Miura, Yumi Manabe, Yu Miyazaki, Mutsuki Mishina, Je Tae Woo, Naoki Sakane, Hiroshi Okuno
J Clin Med. 2023 Apr 7;12(8):2757.
- Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN study.
- Tohi Y, Ishikawa R, Kato T, Miyakawa J, Matsumoto R, Mori K, Mitsuzuka K, Inokuchi J, Matsumura M, Shiga K, Naito H, Kohjimoto Y, Kawamura N, Inoue M, Kinoshita H, Hashimoto K, Goto K, Haba R, Kakehi Y, Sugimoto M
Int J Clin Oncol. 2023 Feb;28(2):299-305. doi: 10.1007/s10147-022-02277-8. Epub 2022 Dec 6. PMID: 36472710.
- Active surveillance in younger patients with prostate cancer: clinical characteristics including longitudinal patient-reported outcomes.
- Tohi Y, Kato T, Matsuda I, Honda T, Osaki Y, Naito H, Matsuoka Y, Okazoe H, Taoka R, Ueda N, Sugimoto M
Jpn J Clin Oncol. 2023 Mar 30;53(4):335-342. doi: 10.1093/jjco/hyac201. PMID: 36579759.
- Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort.
- Tohi Y, Ishikawa R, Kato T, Miyakawa J, Matsumoto R, Mori K, Mitsuzuka K, Inokuchi J, Matsumura M, Shiga K, Naito H, Kohjimoto Y, Kawamura N, Inoue M, Akamatsu S, Terada N, Miyazawa Y, Narita S, Haba R, Sugimoto M.
Jpn J Clin Oncol. 2023 Oct 4;53(10):984-990. doi: 10.1093/jjco/hyad088. PMID: 37496400.
- Development and internal validation of a screening tool for chronic prostatitis (S-CP).
- Tohi Y, Hijikata Y, Sugimoto M, Kuroda H, Takei M, Matsuki T, Kamitani T, Kakehi Y, Fukuhara S, Yamamoto Y.
World J Urol. 2023 Oct;41(10):2759-2765. doi: 10.1007/s00345-023-04574-x. Epub 2023 Sep 15.
PMID: 37712967; PMCID: PMC10582131.
- Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium.
- Tohi Y, Kato T, Kobayashi K, Daizumoto K, Fukuhara H, Ohira S, Katayama S, Shimizu R, Takamoto A,Nishimura K, Ikeda K, Nagami T, Hayashida Y, Hirama H, Naito H, Tomida R, Sasaki Y, Yamamoto S, Shimizu S, Sugimoto M
Jpn J Clin Oncol. 2023 Oct 14:hyad143. doi: 10.1093/jjco/hyad143. Epub ahead of print. PMID: 37840362.
- Aggressive Prostate Cancer in Patients Treated with Active Surveillance.
- Tohi Y, Kato T, Sugimoto M
Cancers (Basel). 2023 Aug 25;15(17):4270. doi: 10.3390/cancers15174270. PMID: 37686546; PMCID: PMC10486407.
- Effectiveness and Safety of a Mixture of Nobiletin and Tangeretin in Nocturia Patients: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study
- Haruki Ito, Hiromitsu Negoro, Jin Kono, Naoki Hayata, Takayoshi Miura, Yumi Manabe, Yu Miyazaki, Mutsuki Mishina, Je Tae Woo, Naoki Sakane, Hiroshi Okuno
J Clin Med. 2023 Apr 7;12(8):2757.
- Incidental finding of extramammary Paget's disease during active surveillance for early-stage prostate cancer in a prostate biopsy
- Kengo Fujiwara, Takuma Kato, Emi Ibuki, Nachino Kimura, Yo Kaku, Hiroyuki Tsunemori, Takayoshi Miura, Teruki Dainichi, Reiji Haba, Mikio Sugimoto
IJU Case Rep. 2023 Jul 23;6(5):290-292
